Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
NCT02064166
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Multiple System Atrophy
Interventions
DRUG:
Intranasal Insulin
Sponsor
Peter Novak